questionText: To ask the Secretary of State for Health and Social Care, with reference to his Department’s press release entitled NHS patients and British businesses to benefit from historic changes to medicines access following pharmaceutical partnership with USA, pub
answerText: The Department has already been clear that the estimated costs of the United Kingdom’s medicines pricing commitments are approximately £1 billion in England over the remaining three-years of the Spending Review. The final and longer-term costs of these ch...
heading: NHS: Drugs